Is the Flu a Cold? Symptoms, Testing, and Treatment

Flu and colds share some symptoms, but they differ in severity, treatment, and prevention. Here’s how to tell them apart and what to do about each.

The flu and the common cold are not the same illness. They are caused by entirely different families of viruses, produce overlapping but distinguishable symptom profiles, and carry very different risks. The confusion is understandable: both infect the respiratory tract, both peak in winter, and both can leave you miserable on the couch. But influenza can land otherwise healthy people in the hospital, while the common cold almost never does. Knowing which one you have changes what treatment makes sense, how long you should expect to feel terrible, and whether you need to worry about serious complications.

Different Viruses, Different Diseases

Influenza is caused by influenza viruses, primarily type A and type B. The common cold, by contrast, is caused by a rotating cast of more than 200 virus strains. Rhinoviruses account for roughly 30 to 50 percent of colds, and human coronaviruses (not the one behind COVID-19, but older, milder relatives) cause another 10 to 15 percent. Adenoviruses, respiratory syncytial virus (RSV), enteroviruses, and parainfluenza viruses fill out much of the rest. This diversity is part of why you can catch cold after cold in a single season: immunity to one rhinovirus strain does nothing against the next one.

Influenza viruses have their own version of this problem. Their surface proteins shift and mutate constantly, a process researchers describe as antigenic drift, where small genetic changes accumulate in the virus’s outer coat over time. Occasionally a much larger change occurs when entirely new surface proteins emerge, reshuffling the virus in a way that can spark a pandemic. This constant shape-shifting is why the flu vaccine is reformulated every year and why you can get the flu more than once in a lifetime.

How the Symptoms Compare

Both illnesses can give you a sore throat, a runny nose, and a cough, which is the main reason people conflate them. But the patterns differ. A cold tends to come on gradually, starting with a scratchy throat and progressing to congestion over a day or two. You feel lousy but functional. The flu, on the other hand, often arrives abruptly. One moment you feel fine; a few hours later you are flat on your back with a high fever, muscle aches, and a crushing sense of fatigue that a cold rarely produces.

A qualitative study conducted across Austria, Belgium, and Croatia found that ordinary people consistently pointed to fever, confinement to bed, and overall severity as the features that distinguished flu from a cold in their minds, though their descriptions of onset timing and illness duration were more varied and sometimes inaccurate. The instinct to look for fever is reasonable, since a temperature above 38°C (about 100.4°F) is far more common with influenza than with a typical cold. Still, not every flu case produces a noticeable fever, and some colds can, so fever alone is not a reliable dividing line.

Here is a rough guide to the most useful distinguishing features:

  • Onset: Colds build gradually; flu tends to hit within hours.
  • Fever: Common and often high with flu; uncommon or mild with colds.
  • Body aches: Prominent with flu; mild or absent with colds.
  • Fatigue: Can be severe and last weeks with flu; generally mild with colds.
  • Sneezing and congestion: Hallmarks of a cold; less prominent with flu.
  • Headache: Frequent with flu; occasional with colds.

None of these features is absolute. Plenty of flu cases look mild, and some severe colds can mimic flu. When the distinction matters clinically, you need a test.

Why the Flu Is More Dangerous

The common cold is annoying but almost never dangerous in healthy adults. The flu is a different story. Influenza can trigger a cascade of immune overreaction sometimes called a cytokine storm, in which the body’s own inflammatory response damages lung tissue and other organs. Factors like age, sex, and obesity can influence how intensely this response unfolds.

The most common serious complications of flu involve the lungs. Influenza can cause pneumonia on its own, and it also opens the door to secondary bacterial infections. Among the bacteria that can move in after flu damages the airway lining, Staphylococcus aureus, including drug-resistant strains, is a particularly dangerous culprit with high mortality. Cardiac and neurological complications are less common but do occur across all age groups.

Heart problems deserve special attention. In one study of patients hospitalized with influenza-related pneumonia, about one in four experienced at least one cardiovascular event during their stay. Arrhythmias were most frequent, followed by heart failure, heart attack, and stroke. These are hospitalized patients, not your average healthy adult with the flu at home, but the data underscores how far the flu’s reach extends beyond the respiratory tract.

Who Faces the Greatest Risk

Annual flu epidemics hit the elderly, people with chronic health conditions, and pregnant women the hardest. Young children and people with weakened immune systems are also at elevated risk. For most healthy adults between 18 and 64, the flu is miserable but self-limiting. For those in higher-risk categories, it can progress quickly to something life-threatening.

Pregnancy is a case worth highlighting. A systematic review and meta-analysis of observational studies found that pregnant women who contracted influenza had roughly two and a half times the odds of being hospitalized compared with non-pregnant patients, though the review did not find a significant difference in mortality. The takeaway is that pregnancy raises your chances of ending up in the hospital with flu, even if it does not clearly raise the chance of dying from it. This is one of the reasons flu vaccination is recommended for pregnant women.

How Testing Tells Them Apart

If you just want to know whether you have a cold or the flu, a test is the only way to be certain. Symptoms overlap too much for a confident diagnosis by feel alone. Several categories of tests exist, and they vary widely in speed and accuracy.

Rapid Antigen Tests

The fastest option is a rapid influenza diagnostic test (RIDT), which can return results in 15 to 30 minutes. These are the tests most commonly used in doctors’ offices and urgent care clinics. The catch is that they miss a lot of cases. A meta-analysis found that traditional rapid tests had a pooled sensitivity of about 62 percent, meaning they correctly identified flu in roughly six out of ten people who actually had it. Specificity was high, around 98 percent, so a positive result is trustworthy, but a negative one does not rule out flu. Sensitivity was lower in adults (about 54 percent) than in children (about 67 percent), and lower for influenza B than influenza A.

At-home rapid flu tests have arrived on the market, and their accuracy is in a similar range. One prospective study of an at-home rapid self-test found overall sensitivity of 61 percent and specificity of 95 percent, with sensitivity holding roughly steady whether symptoms had started within the past three days or lasted longer. If you test positive at home, you can be fairly confident. If you test negative but feel terrible with classic flu symptoms, it is worth following up with your doctor.

Newer Rapid Technologies

A newer generation of tests, digital immunoassays (DIAs) and rapid molecular tests (NAATs), offer substantially better accuracy. A systematic review found that DIAs caught about 80 percent of influenza A cases and 77 percent of influenza B cases, while rapid molecular tests detected about 92 percent and 95 percent, respectively. All maintained specificities above 98 percent. These newer tests still return results quickly and represent a significant improvement over the older generation of rapid antigen tests.

Multiplex PCR Panels

When a hospital or clinic needs to know exactly which virus is responsible, multiplex PCR panels can test for a dozen or more respiratory pathogens at once, including influenza A and B, RSV, and sometimes SARS-CoV-2. These panels show sensitivities above 90 percent for influenza A across multiple platforms. Beyond raw accuracy, rapid multiplex testing has practical benefits in hospitals: a meta-analysis found it cut the time to results by about 24 hours, shortened hospital stays by close to a day, and made it more likely that flu-positive patients received antiviral treatment.

Combination panels that simultaneously detect SARS-CoV-2, influenza A/B, and RSV have become standard in many settings since the COVID-19 pandemic, giving clinicians a fast answer about which respiratory virus they are dealing with.

Treating the Flu vs. Treating a Cold

This is where the distinction between flu and cold matters most in practical terms. The common cold has no specific antiviral treatment. You manage symptoms with rest, fluids, and over-the-counter remedies like decongestants and pain relievers. Evidence for popular supplements is underwhelming: a systematic review concluded that vitamin C is unlikely to meaningfully reduce the duration or severity of cold symptoms, and the evidence for zinc and echinacea remains uncertain. A small trial did find that a combination of high-dose vitamin C and zinc reduced runny-nose symptoms over five days, but the study involved fewer than 100 people, which is thin evidence for a strong recommendation.

Influenza, by contrast, has prescription antiviral drugs that can shorten the illness and reduce the risk of complications, especially when started early. The two main options are oseltamivir (Tamiflu) and baloxavir marboxil (Xofluza).

Oseltamivir has been used for over two decades. It works best when started within 48 hours of symptom onset, and it can also be given to household contacts to reduce their risk of getting sick. It is taken twice daily for five days.

Baloxavir marboxil is a newer antiviral that uses a completely different mechanism to block the virus from replicating. In clinical trials, a single oral dose of baloxavir performed comparably to a five-day course of oseltamivir at improving flu symptoms, both in otherwise healthy adults and in people at high risk for complications. The single-dose convenience is a real advantage for people who struggle with multi-day medication courses.

The practical point is this: if you suspect flu, getting tested and seeing a doctor quickly matters because antivirals lose effectiveness the longer you wait. Home-based test-to-treat programs have tried to close this gap. A nationwide U.S. program found that about 60 percent of participants who received a prescription got it within one day of symptom onset, and over 90 percent within five days. Programs like these aim to eliminate the delay between feeling sick and starting treatment.

Aspirin and Children With Flu or Cold Symptoms

One treatment safety issue is worth calling out separately. Aspirin should not be given to children or teenagers with flu-like or cold-like symptoms. The concern is Reye’s syndrome, a rare but serious condition that causes swelling in the brain and liver, typically following a viral illness. Multiple studies have found a strong association between aspirin use during a viral illness in young people and the development of Reye’s syndrome. In one study, all 12 school-aged children with Reye’s syndrome had received aspirin-containing products during their illness, compared with fewer than half of matched controls.

Some researchers have debated the strength of the causal link, noting that Reye’s syndrome can occur without aspirin exposure. However, the weight of evidence has been considered strong enough that public health authorities have long warned against giving aspirin to anyone under 18 during a febrile illness. One detailed analysis of the published literature concluded that aspirin acts as a co-factor in susceptible individuals and that no dose can be considered safe during a viral infection. Use acetaminophen or ibuprofen instead for fever and pain in children.

When Flu and Other Viruses Hit at the Same Time

Since multiple respiratory viruses circulate during the same season, co-infections do happen. The combination that received the most attention during the pandemic was simultaneous infection with influenza and SARS-CoV-2. A systematic review and meta-analysis found that people infected with both viruses at once had about twice the odds of being admitted to the ICU and of needing mechanical ventilation compared to those with COVID-19 alone. The co-infection did not clearly increase the odds of dying, but the increased severity was enough to be clinically meaningful.

Interestingly, not all co-infections are additive in their harm. A mouse-model study found that prior RSV infection actually appeared to offer some protection against SARS-CoV-2 disease severity and reduced SARS-CoV-2 replication. That is an animal study and may not translate directly to humans, but it hints at the complexity of how different viruses interact in the same host. The immune response triggered by one infection can sometimes interfere with another virus, for better or worse.

Why Both Peak in Winter

People often assume cold weather causes colds and flu, but the temperature itself is not the culprit. The seasonality of respiratory viruses has more to do with how the viruses survive outside the body and how people behave. Cold, dry air helps enveloped viruses like influenza and RSV survive longer on surfaces and in airborne droplets. People also spend more time indoors in close proximity during winter, making transmission easier.

Research on viral seasonality has found that enveloped viruses, including influenza A, influenza B, and RSV, show a clear preference for colder temperatures and lower dew points, while non-enveloped viruses like rhinoviruses circulate more steadily throughout the year. This partially explains why you can catch a cold in August but flu season reliably clusters in the colder months. The research also suggests that shifts in meteorological conditions can help predict when one dominant virus is fading and another is about to surge, which is useful for hospitals trying to prepare.

The Economic Side of Influenza

One reason public health authorities push flu vaccination so hard is the sheer economic toll. A systematic review of influenza’s cost burden among working-age adults (18 to 64) found that up to 88 percent of the total economic burden came from indirect costs, meaning missed work, lost productivity, and caregiving time rather than medical bills. When it came to direct medical costs, hospitalizations accounted for up to 75 percent. Costs rose substantially with age and the presence of underlying health conditions, with hospitalization costs for high-risk populations running as much as two and a half times higher than for otherwise healthy people.

The common cold carries its own economic weight through sheer volume: hundreds of millions of cold episodes occur each year in a country the size of the United States, each one resulting in a day or two of reduced productivity. But because colds rarely require medical intervention and almost never lead to hospitalization, the per-case cost is far lower. The flu’s combination of frequency, severity, and the occasional need for intensive care makes it the more expensive disease by a wide margin on a per-case basis. For employers and public health budgets, this makes flu prevention, through vaccination and early treatment, one of the more cost-effective investments available.